Promega Corporation

Anti-ACTIVE® MAPK, JNK and p38 Polyclonal Antibodies and Anti-ACTIVE® Qualified...

Anti-ACTIVE® MAPK, JNK and p38 Polyclonal Antibodies and Anti-ACTIVE® Qualified Secondary Antibody Conjugate Technical Bulletin

Literature # TB262

Promega has developed polyclonal antibodies (pAb) to three members of the Mitogen-Activated Protein Kinase (MAPK) superfamily of enzymes. These enzymes, which play important roles in signal transduction in eukaryotic cells, are MAPK, p38 and JNK. These kinases have interconnected roles in a cascade of signal transduction reactions. The Anti-ACTIVE® pAbs are specific for the dually phosphorylated active forms of MAPK, p38 and JNK and provide tools to measure more accurately activation of these enzymes.

Printed in USA. Revised 1/12.

PDF Icon Complete Protocol PDF (4534kb)

PDF Icon Quick Protocol PDF (91kb)

Prefer a different language?

Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.